Note: Ingredients listed on restricted chemical lists
EC/CAS
9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
>=30-<50
EC/CAS
13674-84-5
Name of the chemical
Tris(2-chloro-1-methylethyl) phosphate
Concentration
>=1-<10
EC/CAS
75-28-5
Name of the chemical
iso-Butan, enthält 0,1% Butadien
Concentration
>=1-<10
EC/CAS
85535-85-9
Name of the chemical
Alkanes, C14-17, chloro
Concentration
>=2.5-<10
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
>=0.1-<1
General Information
Version
9.1
Revision date
2024-06-17
Product name
1K PUR MOUNTING FOAM B2 750 ML
1.2.1 Relevant identified uses
Sealant Construction material
Emergency telephone
+64 9 262 3030
Icons in SDS
Company Information
company name
Wurth NewZealand Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
prodsafe@wuerth.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H222, H229, H315, H317, H319, H330, H334, H335, H351, H362, H372, H413
Hazard statements
Code
Statements
H222
Extremely flammable aerosol
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Aerosols : Category 1 Acute toxicity (Inhalation) : Category 2 Skin corrosion/irritation : Category 2 Serious eye damage/eye irri- tation : Category 2 Respiratory sensitisation : Category 1 Skin sensitisation : Category 1 Carcinogenicity Effects on or via lactation : Category 2 Specific target organ toxicity - : Category 3 single exposure Specific target organ toxicity - : Category 1 repeated exposure Hazardous to the aquatic : Category 4
Environmental hazards
- chronic hazard
Signal word
Danger
Hazard statements
H222 Extremely flammable aerosol. H229 Pressurised container: May burst if heated. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H330 Fatal if inhaled. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 May cause respiratory irritation. H351 Suspected of causing cancer. H362 May cause harm to breast-fed children. H372 Causes damage to organs through prolonged or repeated exposure. H413 May cause long lasting harmful effects to aquatic life.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P211 Do not spray on an open flame or other ignition source. P251 Do not pierce or burn, even after use. P260 Do not breathe spray. P263 Avoid contact during pregnancy and while nursing. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P271 Use only outdoors or in a well-ventilated area. P272 Contaminated work clothing should not be allowed out of the workplace. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection. P284 Wear respiratory protection.
Response
P302 + P352 IF ON SKIN: Wash with plenty of water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical ad- vice/ attention. P337 + P313 If eye irritation persists: Get medical advice/ at- tention. P342 + P311 If experiencing respiratory symptoms: Call a
Storage
P405 Store locked up. P410 + P412 Protect from sunlight. Do not expose to tempera- tures exceeding 50 °C/ 122 °F.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Other hazards which do not result in classification
May displace oxygen and cause rapid suffocation. Excessive exposure may aggravate preexisting asthma and other respiratory disorders (e.g. em- physema, bronchitis, reactive airways dysfunction syndrome).